Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Becton Dickinson And Company (BDX)
NYSE:BDX
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
3.3Last Year’s EPS
3.17Same Quarter Last Year
Strong Buy
Based on 11 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 05, 2025
|% Change Since: -6.99%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a strong Q1 performance with significant revenue growth, shareholder returns, and innovation launches. However, challenges in China, Biosciences, and translational currency impacts were noted as headwinds.Company Guidance
During the call, BD provided updated financial guidance and shared their strategic decision to separate the Biosciences and Diagnostics Solutions business. For the fiscal year 2025, the company affirmed its full-year currency-neutral and organic revenue growth guidance despite a $250 million expected headwind from translational currency effects. BD reported a strong first quarter performance with 9.6% revenue growth, or 3.9% on an organic basis, and a 28% increase in adjusted diluted EPS to $3.43. They achieved a 370 basis point increase in adjusted gross margin and a 340 basis point rise in operating margin. The company returned over $1 billion to shareholders, including $300 million in dividends and a $750 million accelerated share buyback. BD's updated fiscal 2025 adjusted reported EPS guidance is now between $14.30 and $14.60, reflecting a 10% growth at the midpoint.Strong Q1 Financial Performance
BD reported 9.6% revenue growth or 3.9% organic growth. Adjusted diluted EPS grew by 28% to $3.43. The company also delivered 370 basis points in adjusted gross margin expansion and 340 basis points in adjusted operating margin expansion.
Significant Shareholder Returns
BD returned over $1 billion to shareholders in Q1, including $300 million in dividends and a $750 million accelerated share buyback.
Launch of New Innovations
BD launched several new innovations, including the next-gen HemoSphere Alta Monitor, new Swan IQ and ForeSight IQ smart sensors, and EU approval for the Phasix resorbable mesh for preventing incisional hernias.
Separation of Biosciences and Diagnostic Solutions
BD announced its intention to separate its Biosciences and Diagnostic Solutions business to create a pure-play MedTech company and a separate Life Sciences Tools & Diagnostics entity.
---
BDX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BDX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 05, 2025 | $245.06 | $227.21 | -7.28% |
| Nov 07, 2024 | $238.92 | $226.04 | -5.39% |
| Aug 01, 2024 | $238.94 | $233.94 | -2.09% |
| May 02, 2024 | $230.75 | $237.30 | +2.84% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Becton Dickinson And Company (BDX) report earnings?
Becton Dickinson And Company (BDX) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Becton Dickinson And Company (BDX) earnings time?
Becton Dickinson And Company (BDX) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BDX EPS forecast?
BDX EPS forecast for the fiscal quarter 2025 (Q2) is 3.3.
---
